Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userOpen source disease analysis system of cactus by artificial intelligence and image processing
151
0
0.0
(
0
)
Added by
Joshua Pearce
Publication date
2021
fields
Informatics Engineering
and research's language is
English
Ask ChatGPT about the research
No Arabic abstract
There is a growing interest in cactus cultivation because of numerous cacti uses from houseplants to food and medicinal applications. Various diseases impact the growth of cacti. To develop an automated model for the analysis of cactus disease and to be able to quickly treat and prevent damage to the cactus. The Faster R-CNN and YOLO algorithm technique were used to analyze cactus diseases automatically distributed into six groups: 1) anthracnose, 2) canker, 3) lack of care, 4) aphid, 5) rusts and 6) normal group. Based on the experimental results the YOLOv5 algorithm was found to be more effective at detecting and identifying cactus disease than the Faster R-CNN algorithm. Data training and testing with YOLOv5S model resulted in a precision of 89.7% and an accuracy (recall) of 98.5%, which is effective enough for further use in a number of applications in cactus cultivation. Overall the YOLOv5 algorithm had a test time per image of only 26 milliseconds. Therefore, the YOLOv5 algorithm was found to suitable for mobile applications and this model could be further developed into a program for analyzing cactus disease.
rate research
Read More
Dry eye disease (DED) has a prevalence of between 5 and 50%, depending on the diagnostic criteria used and population under study. However, it remains one of the most underdiagnosed and undertreated conditions in ophthalmology. Many tests used in the diagnosis of DED rely on an experienced observer for image interpretation, which may be considered subjective and result in variation in diagnosis. Since artificial intelligence (AI) systems are capable of advanced problem solving, use of such techniques could lead to more objective diagnosis. Although the term `AI is commonly used, recent success in its applications to medicine is mainly due to advancements in the sub-field of machine learning, which has been used to automatically classify images and predict medical outcomes. Powerful machine learning techniques have been harnessed to understand nuances in patient data and medical images, aiming for consistent diagnosis and stratification of disease severity. This is the first literature review on the use of AI in DED. We provide a brief introduction to AI, report its current use in DED research and its potential for application in the clinic. Our review found that AI has been employed in a wide range of DED clinical tests and research applications, primarily for interpretation of interferometry, slit-lamp and meibography images. While initial results are promising, much work is still needed on model development, clinical testing and standardisation.
To remain aware of the fast-evolving cyber threat landscape, open-source Cyber Threat Intelligence (OSCTI) has received growing attention from the community. Commonly, knowledge about threats is presented in a vast number of OSCTI reports. Despite the pressing need for high-quality OSCTI, existing OSCTI gathering and management platforms, however, have primarily focused on isolated, low-level Indicators of Compromise. On the other hand, higher-level concepts (e.g., adversary tactics, techniques, and procedures) and their relationships have been overlooked, which contain essential knowledge about threat behaviors that is critical to uncovering the complete threat scenario. To bridge the gap, we propose SecurityKG, a system for automated OSCTI gathering and management. SecurityKG collects OSCTI reports from various sources, uses a combination of AI and NLP techniques to extract high-fidelity knowledge about threat behaviors, and constructs a security knowledge graph. SecurityKG also provides a UI that supports various types of interactivity to facilitate knowledge graph exploration.
Artificial intelligence (AI) has significant potential to positively impact and advance medical imaging, including positron emission tomography (PET) imaging applications. AI has the ability to enhance and optimize all aspects of the PET imaging chain from patient scheduling, patient setup, protocoling, data acquisition, detector signal processing, reconstruction, image processing and interpretation. AI poses industry-specific challenges which will need to be addressed and overcome to maximize the future potentials of AI in PET. This paper provides an overview of these industry-specific challenges for the development, standardization, commercialization, and clinical adoption of AI, and explores the potential enhancements to PET imaging brought on by AI in the near future. In particular, the combination of on-demand image reconstruction, AI, and custom designed data processing workflows may open new possibilities for innovation which would positively impact the industry and ultimately patients.
While Moores law has driven exponential computing power expectations, its nearing end calls for new avenues for improving the overall system performance. One of these avenues is the exploration of new alternative brain-inspired computing architectures that promise to achieve the flexibility and computational efficiency of biological neural processing systems. Within this context, neuromorphic intelligence represents a paradigm shift in computing based on the implementation of spiking neural network architectures tightly co-locating processing and memory. In this paper, we provide a comprehensive overview of the field, highlighting the different levels of granularity present in existing silicon implementations, comparing approaches that aim at replicating natural intelligence (bottom-up) versus those that aim at solving practical artificial intelligence applications (top-down), and assessing the benefits of the different circuit design styles used to achieve these goals. First, we present the analog, mixed-signal and digital circuit design styles, identifying the boundary between processing and memory through time multiplexing, in-memory computation and novel devices. Next, we highlight the key tradeoffs for each of the bottom-up and top-down approaches, survey their silicon implementations, and carry out detailed comparative analyses to extract design guidelines. Finally, we identify both necessary synergies and missing elements required to achieve a competitive advantage for neuromorphic edge computing over conventional machine-learning accelerators, and outline the key elements for a framework toward neuromorphic intelligence.
Background: An increasing volume of prostate biopsies and a world-wide shortage of uro-pathologists puts a strain on pathology departments. Additionally, the high intra- and inter-observer variability in grading can result in over- and undertreatment of prostate cancer. Artificial intelligence (AI) methods may alleviate these problems by assisting pathologists to reduce workload and harmonize grading. Methods: We digitized 6,682 needle biopsies from 976 participants in the population based STHLM3 diagnostic study to train deep neural networks for assessing prostate biopsies. The networks were evaluated by predicting the presence, extent, and Gleason grade of malignant tissue for an independent test set comprising 1,631 biopsies from 245 men. We additionally evaluated grading performance on 87 biopsies individually graded by 23 experienced urological pathologists from the International Society of Urological Pathology. We assessed discriminatory performance by receiver operating characteristics (ROC) and tumor extent predictions by correlating predicted millimeter cancer length against measurements by the reporting pathologist. We quantified the concordance between grades assigned by the AI and the expert urological pathologists using Cohens kappa. Results: The performance of the AI to detect and grade cancer in prostate needle biopsy samples was comparable to that of international experts in prostate pathology. The AI achieved an area under the ROC curve of 0.997 for distinguishing between benign and malignant biopsy cores, and 0.999 for distinguishing between men with or without prostate cancer. The correlation between millimeter cancer predicted by the AI and assigned by the reporting pathologist was 0.96. For assigning Gleason grades, the AI achieved an average pairwise kappa of 0.62. This was within the range of the corresponding values for the expert pathologists (0.60 to 0.73).
suggested questions
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
